St. Jude Medical, Inc. (STJ) Tops Q3 EPS by 2c, Guides In-Line; to Buyback $300M in Stock

St. Jude Medical, Inc. (NYSE: STJ) reported Q3 EPS of $0.83, $0.02 better than the analyst estimate of $0.81. Revenue for the quarter came in at $1.33 billion versus the consensus estimate of $1.34 billion.

St. Jude Medical, Inc. sees FY2012 EPS of $3.42-3.44, versus the consensus of $3.43.

St. Jude Medical, Inc. sees Q4 2012 EPS of $0.86-0.88, versus the consensus of $0.89.

The company also announced plans to buyback up to $300 million in stock.

For earnings history and earnings-related data on St. Jude Medical, Inc. (STJ) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
• Pfizer's 25-valent pneumococcal vaccine shows Phase 2 results
• Venture Global rises after QatarEnergy supply talks reported